-
1
-
-
34548660457
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
-
Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 532-555
-
-
Rabe, K.F.1
Hurd, S.2
Anzueto, A.3
-
2
-
-
39049170984
-
Global strategy for asthma management and prevention: GINA executive summary
-
Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
-
(2008)
Eur Respir J
, vol.31
, pp. 143-178
-
-
Bateman, E.D.1
Hurd, S.S.2
Barnes, P.J.3
-
3
-
-
68049084752
-
The overlap syndrome of asthma and COPD: What are its features and how important is it?
-
Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-735.
-
(2009)
Thorax
, vol.64
, pp. 728-735
-
-
Gibson, P.G.1
Simpson, J.L.2
-
4
-
-
0042231982
-
The proportional Venn diagram of obstructive lung disease: Two approximations from the United States and the United Kingdom
-
Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
-
(2003)
Chest
, vol.124
, pp. 474-481
-
-
Soriano, J.B.1
Davis, K.J.2
Coleman, B.3
-
5
-
-
79952591815
-
Overlap syndrome of asthma and COPD predicts low quality of life
-
Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011; 48: 279-285.
-
(2011)
J Asthma
, vol.48
, pp. 279-285
-
-
Kauppi, P.1
Kupiainen, H.2
Lindqvist, A.3
-
6
-
-
80053346631
-
The clinical features of the overlap between COPD and asthma
-
Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011; 12: 127.
-
(2011)
Respir Res
, vol.12
, pp. 127
-
-
Hardin, M.1
Silverman, E.K.2
Barr, R.G.3
-
7
-
-
84858385254
-
Biomarkers in chronic obstructive pulmonary disease
-
Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pulmonary disease. Transl Res 2012; 159: 228-237.
-
(2012)
Transl Res
, vol.159
, pp. 228-237
-
-
Rosenberg, S.R.1
Kalhan, R.2
-
8
-
-
0031059872
-
Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects
-
Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155: 449-453.
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 449-453
-
-
Keatings, V.M.1
Barnes, P.J.2
-
9
-
-
79955113393
-
Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction
-
Ilumets H, Mazur W, Toljamo T, et al. Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm Med 2011; 11: 19.
-
(2011)
BMC Pulm Med
, vol.11
, pp. 19
-
-
Ilumets, H.1
Mazur, W.2
Toljamo, T.3
-
10
-
-
80051518662
-
Elevation of surfactant protein A in plasma and sputum in cigarette smokers
-
Mazur W, Toljamo T, Ohlmeier S, et al. Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur Respir J 2011; 38: 277-284.
-
(2011)
Eur Respir J
, vol.38
, pp. 277-284
-
-
Mazur, W.1
Toljamo, T.2
Ohlmeier, S.3
-
11
-
-
61349158636
-
Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease
-
Ohlmeier S, Vuolanto M, Toljamo T, et al. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 2008; 7: 5125-5132.
-
(2008)
J Proteome Res
, vol.7
, pp. 5125-5132
-
-
Ohlmeier, S.1
Vuolanto, M.2
Toljamo, T.3
-
12
-
-
77951703730
-
Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
-
Ohlmeier S, Mazur W, Salmenkivi K, et al. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Proteomics Clin Appl 2010; 4: 97-105.
-
(2010)
Proteomics Clin Appl
, vol.4
, pp. 97-105
-
-
Ohlmeier, S.1
Mazur, W.2
Salmenkivi, K.3
-
13
-
-
79953687947
-
Reduced soluble receptor for advanced glycation end-products in COPD
-
Smith DJ, Yerkovich ST, Towers MA, et al. Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J 2011; 37: 516-522.
-
(2011)
Eur Respir J
, vol.37
, pp. 516-522
-
-
Smith, D.J.1
Yerkovich, S.T.2
Towers, M.A.3
-
14
-
-
79959778582
-
Soluble receptor for advanced glycation end products in COPD: Relationship with emphysema and chronic cor pulmonale: A case-control study
-
Miniati M, Monti S, Basta G, et al. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res 2011; 12: 37.
-
(2011)
Respir Res
, vol.12
, pp. 37
-
-
Miniati, M.1
Monti, S.2
Basta, G.3
-
15
-
-
84860324666
-
Soluble RAGE is deficient in neutrophilic asthma and COPD
-
Sukkar MB, Wood LG, Tooze M, et al. Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur Respir J 2012; 39: 721-729.
-
(2012)
Eur Respir J
, vol.39
, pp. 721-729
-
-
Sukkar, M.B.1
Wood, L.G.2
Tooze, M.3
-
16
-
-
70350455499
-
Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease
-
Laitinen T, Hodgson U, Kupiainen H, et al. Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease. COPD 2009; 6: 256-262.
-
(2009)
COPD
, vol.6
, pp. 256-262
-
-
Laitinen, T.1
Hodgson, U.2
Kupiainen, H.3
-
17
-
-
49149131364
-
Standardization of spirometry in assessment of responders following man-made disasters: World Trade Center worker and volunteer medical screening program
-
Enright P, Skloot G, Herbert R. Standardization of spirometry in assessment of responders following man-made disasters: World Trade Center worker and volunteer medical screening program. Mt Sinai J Med 2008; 75: 109-114.
-
(2008)
Mt Sinai J Med
, vol.75
, pp. 109-114
-
-
Enright, P.1
Skloot, G.2
Herbert, R.3
-
18
-
-
0020008511
-
Spirometric studies in non-smoking, healthy adults
-
Viljanen AA, Halttunen PK, Kreus KE, et al. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl 1982; 159: 5-20.
-
(1982)
Scand J Clin Lab Invest Suppl
, vol.159
, pp. 5-20
-
-
Viljanen, A.A.1
Halttunen, P.K.2
Kreus, K.E.3
-
19
-
-
43749108171
-
British guideline on the management of asthma
-
British Thoracic Society Scottish Intercollegiate Guidelines Network
-
British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008; 63: Suppl. 4, iv1-iv121.
-
(2008)
Thorax
, vol.63
, Issue.SUPPL. 4
-
-
-
21
-
-
0036728516
-
Standardised methodology of sputum induction and processing
-
Djukanovic R, Sterk PJ, Fahy JV, et al. Standardised methodology of sputum induction and processing. Eur Respir J 2002; 20: Suppl. 37, 1s-2s.
-
(2002)
Eur Respir J
, vol.20
, Issue.SUPPL. 37
-
-
Djukanovic, R.1
Sterk, P.J.2
Fahy, J.V.3
-
22
-
-
0036715472
-
Analysis of fluid-phase mediators
-
Kelly MM, Keatings V, Leigh R, et al. Analysis of fluid-phase mediators. Eur Respir J 2002; 20: Suppl. 37, 24s-39s.
-
(2002)
Eur Respir J
, vol.20
, Issue.SUPPL. 37
-
-
Kelly, M.M.1
Keatings, V.2
Leigh, R.3
-
23
-
-
77949446867
-
Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: A research study
-
Louhelainen N, Stark H, Mazur W, et al. Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study. BMC Pulm Med 2010; 10: 13.
-
(2010)
BMC Pulm Med
, vol.10
, pp. 13
-
-
Louhelainen, N.1
Stark, H.2
Mazur, W.3
-
24
-
-
40049104892
-
Immunology of asthma and chronic obstructive pulmonary disease
-
Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8: 183-192.
-
(2008)
Nat Rev Immunol
, vol.8
, pp. 183-192
-
-
Barnes, P.J.1
-
25
-
-
0035137558
-
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease
-
Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 349-355.
-
(2001)
Am J Respir Crit Care Med
, vol.163
, pp. 349-355
-
-
Aaron, S.D.1
Angel, J.B.2
Lunau, M.3
-
26
-
-
81155152484
-
Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD
-
Liesker JJ, Bathoorn E, Postma DS, et al. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. Respir Med 2011; 105: 1853-1860.
-
(2011)
Respir Med
, vol.105
, pp. 1853-1860
-
-
Liesker, J.J.1
Bathoorn, E.2
Postma, D.S.3
-
27
-
-
0346996867
-
Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha
-
Cowland JB, Sorensen OE, Sehested M, et al. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003; 171: 6630-6639.
-
(2003)
J Immunol
, vol.171
, pp. 6630-6639
-
-
Cowland, J.B.1
Sorensen, O.E.2
Sehested, M.3
-
28
-
-
49749086512
-
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage
-
Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008; 52: 595-605.
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 595-605
-
-
Bolignano, D.1
Donato, V.2
Coppolino, G.3
-
29
-
-
77957857333
-
Neutrophil gelatinase-associated lipocalin: A biomarker in COPD
-
Eagan TM, Damas JK, Ueland T, et al. Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. Chest 2010; 138: 888-895.
-
(2010)
Chest
, vol.138
, pp. 888-895
-
-
Eagan, T.M.1
Damas, J.K.2
Ueland, T.3
-
30
-
-
0034946499
-
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT
-
Ekberg-Jansson A, Andersson B, Bake B, et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med 2001; 95: 363-373.
-
(2001)
Respir Med
, vol.95
, pp. 363-373
-
-
Ekberg-Jansson, A.1
Andersson, B.2
Bake, B.3
-
31
-
-
0032989453
-
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema
-
Betsuyaku T, Nishimura M, Takeyabu K, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 1999; 159: 1985-1991.
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 1985-1991
-
-
Betsuyaku, T.1
Nishimura, M.2
Takeyabu, K.3
-
32
-
-
0035813187
-
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL)
-
Yan L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001; 276: 37258-37265.
-
(2001)
Modulation of MMP-9 Activity by NGAL. J Biol Chem
, vol.276
, pp. 37258-37265
-
-
Yan, L.1
Borregaard, N.2
Kjeldsen, L.3
-
33
-
-
77951979898
-
Induction of neutrophil gelatinase-associated lipocalin expression by costimulation with interleukin-17 and tumor necrosis factor-a is controlled by IkB-f but neither by C/EBP-b nor C/ EBP-d
-
Karlsen JR, Borregaard N, Cowland JB. Induction of neutrophil gelatinase-associated lipocalin expression by costimulation with interleukin-17 and tumor necrosis factor-a is controlled by IkB-f but neither by C/EBP-b nor C/ EBP-d. J Biol Chem 2010; 285: 14088-14100.
-
(2010)
J Biol Chem
, vol.285
, pp. 14088-14100
-
-
Karlsen, J.R.1
Borregaard, N.2
Cowland, J.B.3
-
34
-
-
4444357241
-
Identification of genes differentially expressed in rat alveolar type i cells
-
Dahlin K, Mager EM, Allen L, et al. Identification of genes differentially expressed in rat alveolar type I cells. Am J Respir Cell Mol Biol 2004; 31: 309-316.
-
(2004)
Am J Respir Cell Mol Biol
, vol.31
, pp. 309-316
-
-
Dahlin, K.1
Mager, E.M.2
Allen, L.3
-
35
-
-
32444445050
-
Promotion of cell adherence and spreading: A novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type i cells
-
Demling N, Ehrhardt C, Kasper M, et al. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tiss Res 2006; 323: 475-488.
-
(2006)
Cell Tiss Res
, vol.323
, pp. 475-488
-
-
Demling, N.1
Ehrhardt, C.2
Kasper, M.3
-
36
-
-
48949095796
-
Role of soluble receptor for advanced glycation end products on endotoxininduced lung injury
-
Zhang H, Tasaka S, Shiraishi Y, et al. Role of soluble receptor for advanced glycation end products on endotoxininduced lung injury. Am J Respir Crit Care Med 2008; 178: 356-362.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 356-362
-
-
Zhang, H.1
Tasaka, S.2
Shiraishi, Y.3
-
37
-
-
0036848396
-
Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects
-
Robin M, Dong P, Hermans C, et al. Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J 2002; 20: 1152-1161.
-
(2002)
Eur Respir J
, vol.20
, pp. 1152-1161
-
-
Robin, M.1
Dong, P.2
Hermans, C.3
-
38
-
-
0030984092
-
Effects of cigarette smoking on the serum concentration of lung surfactant protein A (SP-A)
-
Kida K, Oda H, Yamano Y, et al. Effects of cigarette smoking on the serum concentration of lung surfactant protein A (SP-A). Eur Respir J 1997; 10: 2124-2126.
-
(1997)
Eur Respir J
, vol.10
, pp. 2124-2126
-
-
Kida, K.1
Oda, H.2
Yamano, Y.3
-
39
-
-
45749117979
-
Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking
-
Kobayashi H, Kanoh S, Motoyoshi K. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Biomarkers 2008; 13: 385-392.
-
(2008)
Biomarkers
, vol.13
, pp. 385-392
-
-
Kobayashi, H.1
Kanoh, S.2
Motoyoshi, K.3
|